GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

Pakistan · Delayed Price · Currency is PKR

354.20

-13.91 (-3.78%)

At close: Apr 13, 2026

Revenue by Segment

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals		61.19B	49.66B	41.84B	36.66B	35.09B
Pharmaceuticals Growth		23.21%	18.69%	14.13%	4.48%	-4.08%
Total		61.19B	49.66B	41.84B	36.66B	35.09B
Total Growth		23.21%	18.69%	14.13%	4.48%	-4.08%

Revenue by Geography

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Unallocated Sales Tax		-628.93M	-496.75M	-	-	-
Unallocated Commissions, Returns and Discounts		-417.03M	-1.58B	-	-	-
Pakistan		62.22B	51.74B	44.27B	38.12B	36.40B
Pakistan Growth		20.25%	16.88%	16.14%	4.72%	-3.27%
Export		15.86M	-	26.47M	28.88M	16.90M
Export Growth		-	-	-8.36%	70.93%	-70.73%
Unallocated		-	-	-2.45B	-1.49B	-1.33B
Total		61.19B	49.66B	41.84B	36.66B	35.09B
Total Growth		23.21%	18.69%	14.13%	4.48%	-4.08%

Source: S&P Global Market Intelligence.